MASI Stock Overview
Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Masimo Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$124.10 |
| 52 Week High | US$169.58 |
| 52 Week Low | US$75.22 |
| Beta | 0.99 |
| 1 Month Change | -7.92% |
| 3 Month Change | -7.86% |
| 1 Year Change | -24.08% |
| 3 Year Change | -43.05% |
| 5 Year Change | -10.70% |
| Change since IPO | 493.78% |
Recent News & Updates
Masimo: Promising Developments
May 12Analyst Estimates: Here's What Brokers Think Of Masimo Corporation (NASDAQ:MASI) After Its First-Quarter Report
May 10
Recent updates
Masimo: Promising Developments
May 12Analyst Estimates: Here's What Brokers Think Of Masimo Corporation (NASDAQ:MASI) After Its First-Quarter Report
May 10Baron Funds - Masimo Corp.: Can Potentially Double Our Investment
May 05Is There Now An Opportunity In Masimo Corporation (NASDAQ:MASI)?
Apr 13Masimo Corporation's (NASDAQ:MASI) Popularity With Investors Is Under Threat From Overpricing
Mar 28Masimo Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 29Estimating The Intrinsic Value Of Masimo Corporation (NASDAQ:MASI)
Feb 24Masimo: Given The Lack Of Improvement In Revenues And Margins, It Is A Little Expensive
Feb 18These 4 Measures Indicate That Masimo (NASDAQ:MASI) Is Using Debt Extensively
Feb 08Earnings Tell The Story For Masimo Corporation (NASDAQ:MASI) As Its Stock Soars 27%
Dec 23At US$112, Is It Time To Put Masimo Corporation (NASDAQ:MASI) On Your Watch List?
Dec 14Masimo Corporation (NASDAQ:MASI) Shares Could Be 38% Below Their Intrinsic Value Estimate
Nov 09Is Masimo (NASDAQ:MASI) Using Too Much Debt?
Sep 19Is There Now An Opportunity In Masimo Corporation (NASDAQ:MASI)?
Aug 04Here's Why Masimo (NASDAQ:MASI) Has A Meaningful Debt Burden
Jun 20Is It Too Late To Consider Buying Masimo Corporation (NASDAQ:MASI)?
May 05Masimo (NASDAQ:MASI) Seems To Use Debt Quite Sensibly
Mar 22When Should You Buy Masimo Corporation (NASDAQ:MASI)?
Feb 02Does Masimo (NASDAQ:MASI) Have A Healthy Balance Sheet?
Dec 22Is Masimo Corporation (NASDAQ:MASI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 02Shareholder Returns
| MASI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.9% | 1.6% | 1.7% |
| 1Y | -24.1% | 1.8% | 26.3% |
Return vs Industry: MASI underperformed the US Medical Equipment industry which returned 1.7% over the past year.
Return vs Market: MASI underperformed the US Market which returned 26.3% over the past year.
Price Volatility
| MASI volatility | |
|---|---|
| MASI Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: MASI has not had significant price volatility in the past 3 months.
Volatility Over Time: MASI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 3,800 | Joe Kiani | www.masimo.com |
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions.
Masimo Corporation Fundamentals Summary
| MASI fundamental statistics | |
|---|---|
| Market cap | US$6.59b |
| Earnings (TTM) | US$79.10m |
| Revenue (TTM) | US$1.98b |
83.3x
P/E Ratio3.3x
P/S RatioIs MASI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MASI income statement (TTM) | |
|---|---|
| Revenue | US$1.98b |
| Cost of Revenue | US$1.02b |
| Gross Profit | US$960.40m |
| Other Expenses | US$881.30m |
| Earnings | US$79.10m |
Last Reported Earnings
Mar 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.49 |
| Gross Margin | 48.61% |
| Net Profit Margin | 4.00% |
| Debt/Equity Ratio | 64.2% |
How did MASI perform over the long term?
See historical performance and comparison